ProPhase Labs Reports Financial Results for the Three

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2016

DOYLESTOWN, PA --(Marketwired - May 10, 2016) - ProPhase Labs, Inc. ( NASDAQ : PRPH ) ( www.ProPhaseLabs.com ) today reported its net sales were $5.4 million for the three months ended March 31, 2016 as compared to net sales of $5.9 million for the three months ended March 31, 2015. The Company incurred a net loss for the three months ended March 31, 2016, of $1.3 million, or ($0.08) per share, compared to a net loss of $1.4 million, or ($0.09) per share, for the three months ended March 31, 2015.

The Company's sales are derived principally from its over-the-counter health care and cold remedy products. As a consequence, a significant portion of our business is highly seasonal, which causes significant variations in operating results from quarter to quarter. According to IMS Health (a healthcare industry information provider), key industry statistics reveal that the incidence of upper respiratory illness across the country has been down approximately 11% for the period January through March 2016 as compared to the prior year January through March 2015. The category of cough and cold product sales, including our Cold-EEZE ® sales, are highly correlated to the incidence of upper respiratory illness.

Results for the first quarter of 2016 compared to the first quarter of 2015 principally reflect the net effect of (i) a decrease in net sales of $490,000 principally due to (a) the timing of customer purchases and consumer demand as a consequence of the incidence and severity of upper respiratory illnesses, (b) a decrease in operating margins due to fluctuations in our product mix shipped from period to period, offset by and (c) an increase in contract manufacturing net sales which carry lower gross margins, respectively, offset by (ii) a decrease in $482,000 in administration costs due principally to a decrease in legal and professional costs relating to now resolved litigation matters, (iii) a decrease in sales and marketing expenses of $214,000 and (iv) a decrease in research and development expenses of $122,000.

Ted Karkus, the CEO of the Company, stated, "Our product development efforts over the past several years have been largely focused on successfully leveraging the Cold-EEZE ® brand. We have recently met with approximately 80 key retailers and introduced to the trade a new and innovative Cold-EEZE ® branded product that will continue to broaden and strengthen our cough/cold product line for the 2016/2017 cold season."

Mr. Karkus continued, "In order to offset the seasonality of our current revenues and our dependence on the severity of the cold season, we are launching a new product line of over the counter, dietary supplements that will leverage our existing infrastructure, retail relationships and sales force. Our first new product is Legendz XL™, a men's dietary supplement in the male enhancement category. After extensive research and preparation, we have produced our first set of direct response television spots and initiated TV and Digital media testing. We have developed an integrated network of strategic vendors including a call center and a fulfillment center as well as the online infrastructure to execute a direct to consumer marketing and sales strategy. Our new Legendz XL™ website is now live: www.LegendzXL.com . We expect to continually refine our consumer engagement, TV spots, TV media plan and websites during 2016 in order to optimize consumer response and generate product awareness. As with any new product launch, we anticipate losses from the TK Supplements ® initiatives as we optimize our direct response strategy. As brand awareness increases, our next goal will be to introduce Legendz XL™ in retail stores, leveraging our existing infrastructure and retail distribution platform. We also have developed additional dietary supplements for future introduction at the appropriate time."

Mr. Karkus concluded, "We anticipate hosting periodic shareholder conference calls in the future. We recently hosted a shareholder conference call on March 29, 2016 and we plan to host the next conference call when we report our second quarter financial results."

About ProPhase Labs ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE ® cold remedy brand as well as other cold and flu relief products. Cold-EEZE ® cold remedy zinc gluconate lozenges are clinically proven to significantly reduce the duration of the common cold. Cold-EEZE ® cold remedy customers include leading national chain, regional, specialty and local retail stores. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE ® cold remedy lozenges and fulfill other contract manufacturing opportunities. For more information visit us at www.ProPhaseLabs.com .

Forward Looking Statements Except for the historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the launch of our new line of TK Supplements ® , and our new product Legendz XL™. Management believes that these forward-looking statements are reasonable as and when made. However, such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to: the difficulty of predicting the acceptance and demand for our products, the impact of competitive products and pricing, costs involved in the manufacture and marketing of products, the timely development and launch of new products, and the risk factors listed from time to time in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any subsequent SEC filings.

 
 
PROPHASE LABS, INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
 
    Three Months Ended
    March 31, 2016   March 31, 2015
         
Net sales   $ 5,370     $ 5,860  
                 
Cost of sales     2,431       2,198  
                 
Gross profit     2,939       3,662  
                 
Operating expenses:                
  Sales and marketing     2,598       2,812  
  Administration     1,539       2,021  
  Research and development     86       208  
      4,223       5,041  
                 
Loss from operations     (1,284 )     (1,379 )
                 
Interest expense, net     (52 )     (1 )
                 
Loss before income tax     (1,336 )     (1,380 )
                 
Income tax     -       -  
                 
Net loss   $ (1,336 )   $ (1,380 )
                 
Basic and diluted loss per share:                
  Net loss   $ (0.08 )   $ (0.09 )
                 
                 
Weighted average common shares outstanding:                
  Basic and diluted     17,081       15,892  
                   
 
 
PROPHASE LABS, INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET DATA
(in thousands)
(unaudited)
 
    March 31,   December 31,
    2016   2015
         
Cash and cash equivalents   $ 2,457   $ 1,664
Accounts receivable   $ 2,688   $ 4,000
Inventory   $ 4,072   $ 4,331
Total current assets   $ 10,272   $ 11,879
Total assets   $ 13,325   $ 14,829
             
Total current liabilities   $ 4,359   $ 4,534
Other long term obligations   $ 1,472   $ 1,466
Total stockholders' equity   $ 7,494   $ 8,829
             

Investor Contact Ted Karkus Chairman and CEO ProPhase Labs, Inc. (215) 345-0919 x 0

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NVIDIA Faces Fraud Suit: Investors Called to Action

Updated Category News Views 65

NVIDIA and the Quest for Accountability Nothing screams chaos in the market louder than a securities fraud lawsuit hitting the headlines. Investors currently eyeballing NVIDIA Corporation (NASDAQ: NVDA) are in for a wild ride. Yep, you heard it right—NVIDIA is smack in the middle of a class action lawsuit. They're being accused of misleading the market about some shady...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 58

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 116

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
NCPDP Elevates J.W. Hill to President & COO Role

Updated Category News Views 46

Plotting the Course for NCPDP's Future Today's shakeup at the NCPDP has got the sector's ears perked. For those who don't speak in acronym soup all day—NCPDP stands for National Council for Prescription Drug Programs. They're the brains behind many crucial healthcare standards, improving information flow around meds, supplies, and services. Now, they're taking bold...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 170

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Laboratory Filtration Market Expands to $6.55B by 2031

Updated Category News Views 68

A Niche Ready to Explode The laboratory filtration market isn't exactly the sort of thing that grabs headlines in the business section, but its growth is worth giving a second look. By 2031, this market's expected to hit $6.55 billion—up from $4.49 billion in 2026. If you think that's not impressive, chew on a 7.9% CAGR for the next few years. That's like watching your...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 53

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Elah Holdings' Q3 2026 Report Sparks Investor Interest

Updated Category News Views 45

Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 100

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading

Top 5 Most Recently Viewed Articles

Patriot Rail Company Celebrated as a Top Workplace in 2025

Updated Category News Views 218

Patriot Rail Company Achieves Top Workplace Recognition Patriot Rail Company, a leading provider of short line and regional freight rail services, has proudly been recognized as one of the Top Workplaces for 2025 by USA TODAY. This prestigious award celebrates companies that prioritize their employees, ensuring a culture that is rich in support and engagement....

Continue Reading
Transform Your Holiday Spirit with Unique DIY Christmas Ornaments

Updated Category News Views 173

Discover the Joy of DIY Christmas Tree Ornaments As the holiday season approaches, families often seek special ways to celebrate and remember the joy of Christmas. One delightful approach is creating DIY Christmas tree ornaments. Handmade ornaments not only add warmth and creativity to your holiday decor, but they also give a personal touch that store-bought items simply...

Continue Reading
Understanding SkyWest Inc's Price to Earnings Ratio

Updated Category News Views 111

SkyWest Inc's Current Market Performance SkyWest Inc. (NASDAQ: SKYW) is currently seeing its share price at $102.58, marking a notable increase of 1.95% in the recent trading session. However, when looking at the broader picture, the stock has experienced a decline of 17.54% over the last month, while over the last year, the price has surprisingly surged by 20.94%. This...

Continue Reading
Luxury Brands Thrive Amid Positive Sales Trends

Updated Category News Views 366

Luxury Goods Market Experience Significant Upturn Today, shares in prestigious luxury goods companies witnessed a remarkable surge during European trading sessions. This surge follows a compelling end-of-year sales report from Richemont, renowned for its luxurious Cartier brand. The impressive sales performance has ignited optimism about a broader recovery within the...

Continue Reading
Actabl Welcomes Joseph Benjamin as New Technology Leader

Updated Category News Views 240

Actabl Welcomes Joseph Benjamin as New Technology Leader Actabl, a prominent software provider in the hospitality sector, has won a significant addition to its team with the appointment of Joseph Benjamin as the Chief Technology Officer (CTO). Joseph’s presence marks a pivotal moment for Actabl as it enhances its global technology strategies aimed at driving innovation...

Continue Reading